Share Price and Basic Stock Data
Last Updated: February 14, 2026, 8:25 pm
| PEG Ratio | -5.21 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
AVT Natural Products Ltd operates in the agricultural products sector, with a market capitalization of ₹1,082 Cr and a share price of ₹71.00. The company reported total sales of ₹582 Cr for the fiscal year ending March 2023, a modest increase from ₹559 Cr in the previous fiscal year. However, sales exhibited volatility in recent quarters, peaking at ₹160 Cr in September 2022 and declining to ₹103 Cr by June 2023. The revenue showed signs of recovery in subsequent quarters, with ₹135 Cr in September 2023 and ₹154 Cr in December 2023. This fluctuation highlights the company’s susceptibility to market dynamics and operational challenges. The trailing twelve months (TTM) sales stood at ₹622 Cr, indicating a potential rebound in performance. Overall, while AVT has a solid foundation in the agricultural sector, its revenue trends reveal a need for strategic management to stabilize and enhance growth.
Profitability and Efficiency Metrics
AVT Natural Products Ltd reported a net profit of ₹61 Cr for the fiscal year ending March 2023, reflecting a slight increase from ₹77 Cr in the prior year. The operating profit margin (OPM) for the same period was recorded at 21%, showcasing robust profitability, though it declined to 9% in the most recent quarter ending September 2023. The company reported a return on equity (ROE) of 9.89% and a return on capital employed (ROCE) of 12.8%, both metrics suggesting moderate efficiency in utilizing capital to generate profits. The interest coverage ratio (ICR) stood at 9.11x, indicating a strong ability to meet interest obligations. However, the cash conversion cycle (CCC) of 388 days raises concerns about operational efficiency, suggesting that the company may face challenges in managing its working capital effectively. This combination of profitability and efficiency metrics underscores AVT’s potential but also highlights areas for improvement.
Balance Sheet Strength and Financial Ratios
As of March 2025, AVT Natural Products Ltd reported total assets of ₹747 Cr, with total liabilities amounting to ₹747 Cr, indicating a balanced financial structure. The company maintained reserves of ₹508 Cr, providing a cushion for future investments and operational stability. Borrowings stood at ₹100 Cr, reflecting a conservative debt profile with a debt-to-equity ratio of 0.21x. The current ratio of 2.90x indicates strong liquidity, suggesting that the company can comfortably meet its short-term obligations. Furthermore, the price-to-book value (P/BV) ratio of 1.62x suggests that the stock is valued moderately compared to its book value, which stood at ₹33.25 per share. The return on assets (ROA) was recorded at 6.45%, indicating efficient asset utilization. Overall, AVT’s balance sheet reflects a stable financial position, although the company must focus on enhancing its profitability to leverage its asset base more effectively.
Shareholding Pattern and Investor Confidence
AVT Natural Products Ltd has a diverse shareholding structure, with promoters holding a significant 75% stake, which reflects strong control and commitment to the company. The public holds 24.72%, while foreign institutional investors (FIIs) hold a minimal 0.07%, indicating limited foreign interest. Domestic institutional investors (DIIs) possess a slightly higher stake at 0.24%. The number of shareholders has increased substantially from 37,952 in December 2022 to 50,306 in September 2025, signaling growing interest among retail investors. Despite the low foreign institutional investment, the stable promoter holding and increasing public participation suggest a degree of confidence in the company’s long-term prospects. However, the lack of significant institutional backing may limit the stock’s liquidity and attractiveness to larger investors, which could affect overall market sentiment.
Outlook, Risks, and Final Insight
Looking ahead, AVT Natural Products Ltd must navigate several risks, including fluctuating sales that could impact profitability and operational efficiency, as evidenced by the recent decline in quarterly revenue. Additionally, the high cash conversion cycle of 388 days poses a risk to liquidity management, potentially straining cash flows. However, the company’s solid balance sheet, characterized by low debt levels and healthy reserves, provides a buffer against these challenges. Enhancing operational efficiency and stabilizing revenue will be crucial for sustaining profitability. The company’s strong promoter backing and increasing shareholder base are positive indicators for future growth. Should AVT effectively leverage its resources and address operational inefficiencies, it could position itself for improved financial performance and market confidence in the upcoming periods.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 3,393 Cr. | 164 | 186/65.8 | 62.7 | 23.5 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 144 Cr. | 181 | 200/105 | 64.5 | 165 | 0.00 % | 7.35 % | 8.07 % | 10.0 |
| City Crops Agro Ltd | 35.1 Cr. | 21.5 | 28.2/16.8 | 15.8 | 0.00 % | 8.46 % | 8.14 % | 10.0 | |
| Chamanlal Setia Exports Ltd | 1,450 Cr. | 292 | 396/228 | 14.4 | 153 | 0.86 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 404 Cr. | 12.3 | 18.5/11.3 | 14.6 | 6.86 | 0.08 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,814.50 Cr | 238.15 | 29.82 | 106.69 | 0.32% | 11.80% | 12.33% | 4.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 160 | 139 | 134 | 103 | 135 | 154 | 125 | 105 | 122 | 173 | 157 | 132 | 160 |
| Expenses | 126 | 112 | 110 | 92 | 119 | 118 | 109 | 97 | 114 | 143 | 132 | 116 | 145 |
| Operating Profit | 34 | 27 | 24 | 11 | 17 | 36 | 16 | 8 | 8 | 30 | 25 | 16 | 15 |
| OPM % | 21% | 19% | 18% | 11% | 12% | 23% | 13% | 8% | 7% | 17% | 16% | 12% | 9% |
| Other Income | 3 | -1 | -1 | 3 | 5 | -0 | 5 | 5 | 5 | 4 | 2 | 4 | 5 |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 2 | 2 |
| Depreciation | 3 | 4 | 4 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 3 | 3 |
| Profit before tax | 33 | 20 | 18 | 10 | 16 | 30 | 15 | 8 | 8 | 28 | 20 | 15 | 16 |
| Tax % | 25% | 34% | 21% | 19% | 27% | 26% | 26% | 25% | 17% | 23% | 27% | 18% | 16% |
| Net Profit | 25 | 13 | 14 | 8 | 12 | 22 | 11 | 6 | 6 | 22 | 14 | 12 | 13 |
| EPS in Rs | 1.64 | 0.88 | 0.93 | 0.55 | 0.76 | 1.47 | 0.72 | 0.39 | 0.41 | 1.42 | 0.94 | 0.80 | 0.87 |
Last Updated: January 2, 2026, 9:01 am
Below is a detailed analysis of the quarterly data for AVT Natural Products Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 160.00 Cr.. The value appears strong and on an upward trend. It has increased from 132.00 Cr. (Jun 2025) to 160.00 Cr., marking an increase of 28.00 Cr..
- For Expenses, as of Sep 2025, the value is 145.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 116.00 Cr. (Jun 2025) to 145.00 Cr., marking an increase of 29.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Jun 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Jun 2025) to 9.00%, marking a decrease of 3.00%.
- For Other Income, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Jun 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Jun 2025) to 16.00 Cr., marking an increase of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 18.00% (Jun 2025) to 16.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Jun 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.87. The value appears strong and on an upward trend. It has increased from 0.80 (Jun 2025) to 0.87, marking an increase of 0.07.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:36 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 290 | 261 | 274 | 311 | 328 | 339 | 396 | 485 | 559 | 582 | 517 | 556 | 622 |
| Expenses | 216 | 214 | 235 | 269 | 295 | 297 | 339 | 414 | 454 | 461 | 438 | 486 | 537 |
| Operating Profit | 74 | 48 | 39 | 42 | 33 | 42 | 57 | 71 | 106 | 121 | 79 | 70 | 85 |
| OPM % | 25% | 18% | 14% | 14% | 10% | 12% | 14% | 15% | 19% | 21% | 15% | 13% | 14% |
| Other Income | 1 | 2 | 1 | 5 | 13 | 4 | 7 | 8 | 10 | 2 | 13 | 16 | 15 |
| Interest | 2 | 4 | 1 | 2 | 3 | 5 | 6 | 4 | 5 | 5 | 7 | 9 | 10 |
| Depreciation | 5 | 6 | 6 | 7 | 7 | 11 | 14 | 15 | 14 | 13 | 14 | 14 | 13 |
| Profit before tax | 67 | 41 | 33 | 38 | 36 | 30 | 45 | 61 | 97 | 105 | 71 | 63 | 78 |
| Tax % | 37% | 35% | 35% | 36% | 32% | 30% | 24% | 25% | 25% | 26% | 25% | 24% | |
| Net Profit | 42 | 26 | 22 | 24 | 24 | 21 | 34 | 45 | 73 | 77 | 53 | 48 | 61 |
| EPS in Rs | 2.76 | 1.73 | 1.42 | 1.61 | 1.59 | 1.37 | 2.23 | 2.97 | 4.78 | 5.08 | 3.50 | 3.17 | 4.03 |
| Dividend Payout % | 27% | 29% | 28% | 25% | 25% | 29% | 27% | 24% | 21% | 20% | 23% | 25% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -38.10% | -15.38% | 9.09% | 0.00% | -12.50% | 61.90% | 32.35% | 62.22% | 5.48% | -31.17% | -9.43% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.71% | 24.48% | -9.09% | -12.50% | 74.40% | -29.55% | 29.87% | -56.74% | -36.65% | 21.73% |
AVT Natural Products Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 0% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | -13% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | -12% |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 12:10 am
Balance Sheet
Last Updated: December 4, 2025, 1:00 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 152 | 171 | 185 | 209 | 223 | 236 | 260 | 295 | 354 | 415 | 454 | 491 | 508 |
| Borrowings | 5 | 7 | 10 | 15 | 36 | 81 | 46 | 54 | 25 | 37 | 43 | 113 | 100 |
| Other Liabilities | 64 | 44 | 39 | 36 | 55 | 56 | 57 | 62 | 55 | 56 | 86 | 128 | 169 |
| Total Liabilities | 237 | 237 | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 524 | 598 | 747 | 792 |
| Fixed Assets | 51 | 53 | 58 | 57 | 56 | 98 | 99 | 89 | 82 | 78 | 82 | 72 | 63 |
| CWIP | 0 | 2 | 1 | 0 | 28 | 0 | 0 | 0 | 2 | 0 | 0 | 4 | 14 |
| Investments | 15 | 7 | 28 | 38 | 30 | 7 | 8 | 8 | 28 | 58 | 127 | 136 | 115 |
| Other Assets | 171 | 175 | 162 | 180 | 215 | 283 | 271 | 329 | 337 | 387 | 390 | 535 | 600 |
| Total Assets | 237 | 237 | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 524 | 598 | 747 | 792 |
Below is a detailed analysis of the balance sheet data for AVT Natural Products Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Reserves, as of Sep 2025, the value is 508.00 Cr.. The value appears strong and on an upward trend. It has increased from 491.00 Cr. (Mar 2025) to 508.00 Cr., marking an increase of 17.00 Cr..
- For Borrowings, as of Sep 2025, the value is 100.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 113.00 Cr. (Mar 2025) to 100.00 Cr., marking a decrease of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 169.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 128.00 Cr. (Mar 2025) to 169.00 Cr., marking an increase of 41.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 792.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 747.00 Cr. (Mar 2025) to 792.00 Cr., marking an increase of 45.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Mar 2025) to 63.00 Cr., marking a decrease of 9.00 Cr..
- For CWIP, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 10.00 Cr..
- For Investments, as of Sep 2025, the value is 115.00 Cr.. The value appears to be declining and may need further review. It has decreased from 136.00 Cr. (Mar 2025) to 115.00 Cr., marking a decrease of 21.00 Cr..
- For Other Assets, as of Sep 2025, the value is 600.00 Cr.. The value appears strong and on an upward trend. It has increased from 535.00 Cr. (Mar 2025) to 600.00 Cr., marking an increase of 65.00 Cr..
- For Total Assets, as of Sep 2025, the value is 792.00 Cr.. The value appears strong and on an upward trend. It has increased from 747.00 Cr. (Mar 2025) to 792.00 Cr., marking an increase of 45.00 Cr..
Notably, the Reserves (508.00 Cr.) exceed the Borrowings (100.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 69.00 | 41.00 | 29.00 | 27.00 | -3.00 | -39.00 | 11.00 | 17.00 | 81.00 | 84.00 | 36.00 | -43.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 58 | 69 | 65 | 71 | 88 | 69 | 77 | 67 | 76 | 78 | 103 |
| Inventory Days | 248 | 278 | 184 | 205 | 186 | 341 | 235 | 258 | 263 | 342 | 365 | 431 |
| Days Payable | 59 | 37 | 28 | 39 | 68 | 82 | 43 | 59 | 45 | 44 | 98 | 146 |
| Cash Conversion Cycle | 236 | 300 | 226 | 231 | 188 | 347 | 261 | 275 | 284 | 373 | 345 | 388 |
| Working Capital Days | 114 | 159 | 143 | 119 | 116 | 166 | 151 | 159 | 163 | 176 | 171 | 172 |
| ROCE % | 40% | 25% | 17% | 17% | 14% | 11% | 15% | 19% | 27% | 26% | 16% | 13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| Diluted EPS (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| Cash EPS (Rs.) | 4.08 | 4.41 | 5.96 | 5.73 | 3.97 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 33.25 | 30.83 | 28.26 | 24.21 | 20.37 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 33.25 | 30.83 | 28.26 | 24.21 | 20.37 |
| Revenue From Operations / Share (Rs.) | 36.51 | 33.97 | 38.23 | 36.73 | 31.86 |
| PBDIT / Share (Rs.) | 5.68 | 6.04 | 8.09 | 7.59 | 5.24 |
| PBIT / Share (Rs.) | 4.77 | 5.12 | 7.22 | 6.65 | 4.24 |
| PBT / Share (Rs.) | 4.15 | 4.67 | 6.86 | 6.35 | 3.98 |
| Net Profit / Share (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| NP After MI And SOA / Share (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| PBDIT Margin (%) | 15.55 | 17.76 | 21.17 | 20.66 | 16.43 |
| PBIT Margin (%) | 13.06 | 15.08 | 18.87 | 18.10 | 13.30 |
| PBT Margin (%) | 11.35 | 13.73 | 17.95 | 17.27 | 12.48 |
| Net Profit Margin (%) | 8.67 | 10.30 | 13.29 | 13.02 | 9.33 |
| NP After MI And SOA Margin (%) | 8.67 | 10.30 | 13.29 | 13.02 | 9.33 |
| Return on Networth / Equity (%) | 9.52 | 11.34 | 17.98 | 19.75 | 14.59 |
| Return on Capital Employeed (%) | 14.00 | 16.08 | 24.68 | 26.53 | 19.69 |
| Return On Assets (%) | 6.45 | 8.90 | 14.83 | 16.23 | 10.64 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Total Debt / Equity (X) | 0.21 | 0.07 | 0.07 | 0.05 | 0.15 |
| Asset Turnover Ratio (%) | 0.82 | 0.92 | 1.21 | 1.24 | 1.18 |
| Current Ratio (X) | 2.90 | 4.53 | 5.75 | 5.37 | 3.40 |
| Quick Ratio (X) | 1.62 | 2.57 | 2.98 | 2.64 | 1.72 |
| Inventory Turnover Ratio (X) | 2.16 | 0.94 | 1.45 | 1.49 | 1.84 |
| Dividend Payout Ratio (NP) (%) | 25.26 | 25.71 | 19.67 | 16.72 | 21.85 |
| Dividend Payout Ratio (CP) (%) | 19.62 | 20.40 | 16.77 | 13.96 | 16.37 |
| Earning Retention Ratio (%) | 74.74 | 74.29 | 80.33 | 83.28 | 78.15 |
| Cash Earning Retention Ratio (%) | 80.38 | 79.60 | 83.23 | 86.04 | 83.63 |
| Interest Coverage Ratio (X) | 9.11 | 13.20 | 23.02 | 25.04 | 19.89 |
| Interest Coverage Ratio (Post Tax) (X) | 6.08 | 8.65 | 15.46 | 16.78 | 12.30 |
| Enterprise Value (Cr.) | 894.31 | 1285.96 | 1216.71 | 1993.77 | 716.44 |
| EV / Net Operating Revenue (X) | 1.61 | 2.49 | 2.09 | 3.56 | 1.48 |
| EV / EBITDA (X) | 10.34 | 13.99 | 9.87 | 17.24 | 8.99 |
| MarketCap / Net Operating Revenue (X) | 1.48 | 2.47 | 2.07 | 3.55 | 1.41 |
| Retention Ratios (%) | 74.73 | 74.28 | 80.32 | 83.27 | 78.14 |
| Price / BV (X) | 1.62 | 2.72 | 2.80 | 5.39 | 2.21 |
| Price / Net Operating Revenue (X) | 1.48 | 2.47 | 2.07 | 3.55 | 1.41 |
| EarningsYield | 0.05 | 0.04 | 0.06 | 0.03 | 0.06 |
After reviewing the key financial ratios for AVT Natural Products Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.17. This value is below the healthy minimum of 5. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.17. This value is below the healthy minimum of 5. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For Cash EPS (Rs.), as of Mar 25, the value is 4.08. This value is within the healthy range. It has decreased from 4.41 (Mar 24) to 4.08, marking a decrease of 0.33.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 33.25. It has increased from 30.83 (Mar 24) to 33.25, marking an increase of 2.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 33.25. It has increased from 30.83 (Mar 24) to 33.25, marking an increase of 2.42.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 36.51. It has increased from 33.97 (Mar 24) to 36.51, marking an increase of 2.54.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.68. This value is within the healthy range. It has decreased from 6.04 (Mar 24) to 5.68, marking a decrease of 0.36.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.77. This value is within the healthy range. It has decreased from 5.12 (Mar 24) to 4.77, marking a decrease of 0.35.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.15. This value is within the healthy range. It has decreased from 4.67 (Mar 24) to 4.15, marking a decrease of 0.52.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.17. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.17. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For PBDIT Margin (%), as of Mar 25, the value is 15.55. This value is within the healthy range. It has decreased from 17.76 (Mar 24) to 15.55, marking a decrease of 2.21.
- For PBIT Margin (%), as of Mar 25, the value is 13.06. This value is within the healthy range. It has decreased from 15.08 (Mar 24) to 13.06, marking a decrease of 2.02.
- For PBT Margin (%), as of Mar 25, the value is 11.35. This value is within the healthy range. It has decreased from 13.73 (Mar 24) to 11.35, marking a decrease of 2.38.
- For Net Profit Margin (%), as of Mar 25, the value is 8.67. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 8.67, marking a decrease of 1.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.67. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 8.67, marking a decrease of 1.63.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.52. This value is below the healthy minimum of 15. It has decreased from 11.34 (Mar 24) to 9.52, marking a decrease of 1.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.00. This value is within the healthy range. It has decreased from 16.08 (Mar 24) to 14.00, marking a decrease of 2.08.
- For Return On Assets (%), as of Mar 25, the value is 6.45. This value is within the healthy range. It has decreased from 8.90 (Mar 24) to 6.45, marking a decrease of 2.45.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.21, marking an increase of 0.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.82. It has decreased from 0.92 (Mar 24) to 0.82, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 2.90. This value is within the healthy range. It has decreased from 4.53 (Mar 24) to 2.90, marking a decrease of 1.63.
- For Quick Ratio (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has decreased from 2.57 (Mar 24) to 1.62, marking a decrease of 0.95.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.16. This value is below the healthy minimum of 4. It has increased from 0.94 (Mar 24) to 2.16, marking an increase of 1.22.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 25.26. This value is within the healthy range. It has decreased from 25.71 (Mar 24) to 25.26, marking a decrease of 0.45.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.62. This value is below the healthy minimum of 20. It has decreased from 20.40 (Mar 24) to 19.62, marking a decrease of 0.78.
- For Earning Retention Ratio (%), as of Mar 25, the value is 74.74. This value exceeds the healthy maximum of 70. It has increased from 74.29 (Mar 24) to 74.74, marking an increase of 0.45.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.38. This value exceeds the healthy maximum of 70. It has increased from 79.60 (Mar 24) to 80.38, marking an increase of 0.78.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.11. This value is within the healthy range. It has decreased from 13.20 (Mar 24) to 9.11, marking a decrease of 4.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.08. This value is within the healthy range. It has decreased from 8.65 (Mar 24) to 6.08, marking a decrease of 2.57.
- For Enterprise Value (Cr.), as of Mar 25, the value is 894.31. It has decreased from 1,285.96 (Mar 24) to 894.31, marking a decrease of 391.65.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.61. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 1.61, marking a decrease of 0.88.
- For EV / EBITDA (X), as of Mar 25, the value is 10.34. This value is within the healthy range. It has decreased from 13.99 (Mar 24) to 10.34, marking a decrease of 3.65.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 1.48, marking a decrease of 0.99.
- For Retention Ratios (%), as of Mar 25, the value is 74.73. This value exceeds the healthy maximum of 70. It has increased from 74.28 (Mar 24) to 74.73, marking an increase of 0.45.
- For Price / BV (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has decreased from 2.72 (Mar 24) to 1.62, marking a decrease of 1.10.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 1.48, marking a decrease of 0.99.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AVT Natural Products Ltd:
- Net Profit Margin: 8.67%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14% (Industry Average ROCE: 11.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.52% (Industry Average ROE: 12.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.5 (Industry average Stock P/E: 29.82)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.21
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.67%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | 60, Rukmani Lakshmipathy Salai, Chennai (Madras) Tamil Nadu 600008 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ajit Thomas | Chairman |
| Mr. A D Bopana | Director |
| Mrs. Shanthi Thomas | Director |
| Mrs. Kavitha Vijay | Director |
| Mr. M M Venkatachalam | Director |
| Mr. Ranganath N Krishna | Director |
| Mr. Rahul Thomas | Director |
FAQ
What is the intrinsic value of AVT Natural Products Ltd?
AVT Natural Products Ltd's intrinsic value (as of 15 February 2026) is ₹46.52 which is 29.30% lower the current market price of ₹65.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,002 Cr. market cap, FY2025-2026 high/low of ₹83.8/51.0, reserves of ₹508 Cr, and liabilities of ₹792 Cr.
What is the Market Cap of AVT Natural Products Ltd?
The Market Cap of AVT Natural Products Ltd is 1,002 Cr..
What is the current Stock Price of AVT Natural Products Ltd as on 15 February 2026?
The current stock price of AVT Natural Products Ltd as on 15 February 2026 is ₹65.8.
What is the High / Low of AVT Natural Products Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of AVT Natural Products Ltd stocks is ₹83.8/51.0.
What is the Stock P/E of AVT Natural Products Ltd?
The Stock P/E of AVT Natural Products Ltd is 17.5.
What is the Book Value of AVT Natural Products Ltd?
The Book Value of AVT Natural Products Ltd is 34.4.
What is the Dividend Yield of AVT Natural Products Ltd?
The Dividend Yield of AVT Natural Products Ltd is 1.06 %.
What is the ROCE of AVT Natural Products Ltd?
The ROCE of AVT Natural Products Ltd is 12.8 %.
What is the ROE of AVT Natural Products Ltd?
The ROE of AVT Natural Products Ltd is 9.89 %.
What is the Face Value of AVT Natural Products Ltd?
The Face Value of AVT Natural Products Ltd is 1.00.